A carregar...
NSAIDs: the Emperor’s new dogma?
The spectacular marketing success of the selective cyclooxygenase 2 (COX-2) inhibitors is largely based on efficacy comparable with conventional non-steroidal anti-inflammatory drugs (NSAIDs) with vastly improved gastrointestinal safety. The additional key to the marketing success is the purity and...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Copyright 2003 by Gut
2003
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1773807/ https://ncbi.nlm.nih.gov/pubmed/12912873 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|